The coverage of the pharmaceutical industry risks is of concern to insurers

The conviction of Merck laboratory by first instance court and imposition of a 253 million USD-payment in damages and interests for the anti-inflammatory Vioxx deemed hazardous raised serious concerns among business professionals over the coverage of risks pertaining to the pharmaceutical industry.